CJ Barnum

CJ Barnum

Company: INmune Bio

Job title: Head of Neuroscience

Seminars:

Live Q&A With Your Expert Speakers 3:00 pm

Read more

day: Day Two

What it Means to Demonstrate Target Engagement in Therapies that Target the Immune System: Role of Combination of Biomarkers. 2:00 pm

Assessing target engagement of inflammatory treatments via multiple platforms and assays; why is it necessary? “Anti-inflammatory” is not enough: Demonstrate downstream consequences of targeting inflammation Integrating novel, non-invasive biomarkers, in early-stage trials – potential and limitations.Read more

day: Day Two

Live Q&A With Your Expert Speakers 12:15 pm

Read more

day: Day Two

Biomarkers to Evaluate Therapies that Target the Immune System in Early-Stage Alzheimer’s Trials: Patient Selection, Target Engagement, & Promising Technologies 11:15 am

Biomarkers to select patients most likely to respond to treatment Using Biomarkers to determine target engagement and demonstrate safety; inflammatory biomarkers are not enough Non-invasive biomarkers to predict treatment responseRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.